← Volver a los artículos

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH confianza neutral tono

Cobertura (16258 artículos)

Reuters · Aug 27, 2026

China approves Novo Nordisk's oral Wegovy application

China's drug regulator has accepted Novo Nordisk's application for oral Wegovy, marking regulatory progress for the popular weight-loss medication in the world's second-largest pharmaceutical market.

← Anterior Página 64 de 678 Siguiente →
Contáctanos FAQ